Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1– and 2–infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

2021 ◽  
Author(s):  
Toshifumi Tada ◽  
Masayuki Kurosaki ◽  
Shinichiro Nakamura ◽  
Chitomi Hasebe ◽  
Yuji Kojima ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Multicenter Study ◽  
Real World ◽  
Red Cross ◽  
Decompensated Cirrhosis ◽  
Study Group ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1

scholarly journals Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

2019 ◽  
Vol 49 (10) ◽  
pp. 1114-1120 ◽  
Author(s):  
Toshie Mashiba ◽  
Kouji Joko ◽  
Masayuki Kurosaki ◽  
Hironori Ochi ◽  
Chitomi Hasebe ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Multicenter Study ◽  
Real World ◽  
Red Cross ◽  
Study Group ◽  
Genotype 1 ◽  
Virus Genotype

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

2017 ◽  
Vol 66 (6) ◽  
pp. 1138-1148 ◽  
Author(s):  
Jose Luis Calleja ◽  
Javier Crespo ◽  
Diego Rincón ◽  
Belén Ruiz-Antorán ◽  
Inmaculada Fernandez ◽  
...  
Keyword(s):  
Antiviral Therapy ◽  
Clinical Outcomes ◽  
Real World ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Direct Acting Antiviral ◽  
Hcv Genotype 1 ◽  
Direct Acting

scholarly journals High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain

2015 ◽  
Vol 14 (4) ◽  
pp. 477-486 ◽  
Author(s):  
Javier Crespo ◽  
Moisés Diago ◽  
Joaquín Cabezas ◽  
Marina Berenguer ◽  
Teresa Broquetas ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Triple Therapy ◽  
Multicenter Study ◽  
Efficacy And Safety ◽  
Genotype 1 ◽  
High Efficacy ◽  
Hcv Genotype ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document